Rosehip is part of the fruit that grows on the blossom of a wild rose called Rosa Canina. This rose grows mostly in Europe and parts of Africa and Asia – the plant grows up to ten feet tall and bears a white, very fragrant flower. Once the flower has bloomed, and all the petals have fallen off, the hip is picked and used in a wide variety of preparations.
Rosehips are high in beneficial micronutrients and phytonutrients such as vitamins A, B, C, E and K, and flavonoids. Rosehips contain as much as 20 x more vitamin C than oranges; a single tablespoon of rosehip pulp gives an adult more than the recommended daily allowance of 60 mg of Vitamin C.
Vitamin A is also beneficial to the immune system. It can help to prevent infections from both bacteria and viruses and fight off any infections that do occur.
Rosehips are often thought of as a great cancer preventative because they have carotenoids, polyphenols, flavonoids, leucoanthocyanins, and catechins.
Rosehips can be eaten raw, after being put through a blender, or soaked in water overnight and then cooked in the water for about half an hour.
Treatments for childhood cancers have improved to the point that 5-year survival rates are over 80 %.
However, one group has failed to benefit from these improvements, namely children who die so soon after diagnosis that they are not able to receive treatment, or who receive treatment so late in the course of their disease that it is destined to fail.
A study published in the Journal of Clinical Oncology explores this challenging population, finding that death within a month of diagnosis is more likely in very young children and those from minority racial and ethnic groups even independent of low socioeconomic status.
The study uses a large national database to find that the rate of deaths within one month of diagnosis has been previously under-reported in clinical trial data, with early deaths from some paediatric cancer subtypes up to four times as common as had been implied by clinical trial reports.
While Gene Therapy has been around for a few years already, we don’t seem to be hearing much about it being used to treat cancer, especially paediatric cancer, and one cannot help but wonder why…
In most gene therapy studies, a “normal” gene is inserted into the genome to replace an “abnormal,” disease-causing gene. In cancer, some cells become diseased because certain genes have been permanently turned off. Using gene therapy, mutated genes that cause disease could be turned off so that they no longer promote disease, or healthy genes that help prevent disease could be turned on so that they can inhibit the disease.
Other cells may be missing certain genes. Researchers hope that replacing missing or defective genes can help treat certain diseases. For example, a common tumor suppressor gene called p53 normally prevents tumor growth in your body. Several types of cancer have been linked to a missing or inactive p53 gene. If doctors could replace p53 where it’s missing, that might trigger the cancer cells to die.
Back in 2014, researchers published the results of a study in the journal PLoS One that showed the complete destruction of tumours, without relapse, in 75% of laboratory mice treated with direct injections of EBC-46 into the cancerous cells. In some cases, this destruction occurred in as little as 48 hours.
Dr. Glen Boyle was the lead author of that study, conducted by a team of cancer scientists at the Queensland Institute of Medical Research, Australia as well as the private pharmaceutical company QBiotics. The team extracted a compound from seeds contained in the berry of the Blushwood tree (Fontainea picrosperma), which only grows in the Atherton Tablelands, an area of Rainforest in the North of Queensland.
At the time, Boyle stated that “in most cases a single injection starts killing the cancer off in 4-5 hours.” He also said “the compound works in three ways – it kills the tumour, cuts off the blood supply and activates the immune system to clear it all up.”
In extremely broad brushstrokes, researchers posit that the compound achieves these goals primarily by activating an enzyme called Protein Kinase C, though the exact mechanisms remain unclear.
In December 2016 an article entitled “Scientists find Australian berry to cure cancer in 48 hours!” started doing the rounds and is still being widely shared, but is this 100% true??
According to a statement issued by Bell Media, the 41-year old entertainer has pulled out of hosting Canada’s biggest music awards show, the Juno Awards, that is scheduled to be held on April 2.
Iconic rocker Bryan Adams and megastar comedian Russell Peters are set to take the stage as co-hosts.
The Little Fighters Cancer Trust joins in the rest of the world in taking its hat off to Michael for doing the right thing and putting his focus on his family and his son’s battle with cancer as we more than most realise that when a child has cancer the whole family is affected and the one thing that child needs most is the support of loving parents.
“Our thoughts continue to be with Michael — we respect his ongoing commitment to his family and look forward to working with him again in the future,” the statement reads.
Those who have survived cancer are often left with a different appreciation of life, even children who have not yet lived much of theirs.
Survivors can also, however, become very anxious about their health; about whether the cancer will return; about the visits to the doctor for the next how many ever years, and then when the regular visits stop.
Another problem is that unless you have had cancer or have cared for someone who has survived cancer, there is NO WAY you can understand what a cancer Survivor goes through for the rest of their life! Most people seem to think that having cancer is a temporary situation and that once you are through the treatments it means that you are cured and life should just continue as per normal – this is FAR from the truth!
Cancer is in effect a revolving door, and at any moment a scan could land a Survivor right back in the territory of Active Cancer Treatment
Helen and mommy Siobahn here again – today we are going to continue with “Helen’s Story” because we want everyone out there to know about Childhood Cancer and about my cancer, Retinoblastoma.
Now that the problem had been diagnosed as Retinoblastoma, things moved along very quickly. The diagnosis was made on the Thursday and the operation to remove the eye was scheduled for the next Monday.
Helen underwent an MRI Scan as well as a Lumbar Puncture in order to determine whether cancer was present anywhere else in Helen’s body. Fortunately all tests came back negative and it was determined that the cancer was confined to Helen’s left eye.
Helen underwent surgery to remove the eye and she and mommy stayed overnight in ICU and in the normal Paediatric ward the next night, during which time Helen she had a plaster over her eye. The plaster was removed before she went home the next day and replaced by a transparent shield to prevent infection and was removed two weeks later.
A ball implant was inserted into the empty eye socket and Helen currently wears nothing over the eye – she will get a prosthesis when she is a little bit older and able to handle the hygiene it requires (toddlers tend to play in the sand or touch unhygienic toys etc. and then rub their eyes).
my name is Helen and my mommy and I would like to share my story with you so that more people can get to know about Childhood Cancer; in this case specifically Retinoblastoma.
Retinoblastoma is a type of eye cancer that develops in the light-sensitive lining of the eye, called the retina, and can occur at any age but mainly occurs in children younger than 5 years of age and most often in those younger than 2.
Retinoblastoma may occur in one or both eyes, but rarely spreads to other parts of the body. Although it is the most common eye tumour in children, it is a rare childhood cancer and accounts for about 3-4% of childhood cancers.
The main challenge of treating Retinoblastoma is the prevention of blindness, however approximately 98% of children with retinoblastoma are cured.
Research done by St Jude Children’s Research Hospital shows that Childhood Cancer survival rates are on the rise and that children are seeing fewer new tissue growths as well as fewer complications later on. Researchers say that this decline is due to a sharp drop in the use of radiation therapy.
Radiation treatment in paediatric cancers has been cut by nearly half since 1970; the percentage of pediatric cancer patients treated with radiation fell from 77% to 33%. The average radiation dose has also lessened.
Radiation therapy was long seen as the standard treatment for treating various cancers, but in recent years, scientists have learned that the probability of second cancers increases as the radiation dose increases. Radiation kills off the cancerous tissue, but the downside is that it is very difficult to localise the high energy X-rays and they often hit other uninfected tissues, which can cause a second cancer to develop.
A comprehensive initiative called Global HOPE (Haematology-Oncology Paediatric Excellence) has recently been launched in public-private partnerships between American institutions and the governments of Botswana, Uganda and Malawi.
The $100m Paediatric Haematology-Oncology treatment network has been created in order to build long-term capacity to treat and dramatically improve the prognosis of thousands of children with cancer and blood disorders in southern and eastern Africa.
There are currently only 5 paediatric oncologists in Botswana, Malawi and Uganda combined, which is totally inadequate to deal with the scourge of Childhood Cancer.
“We believe in these countries there are more than 11,000 new cases annually of paediatric cancer and 40,000 new cases of serious, life-threatening blood disorders such as sickle cell disease and haemophilia. Because of these staggering numbers, more healthcare providers with special expertise are urgently needed,” said David G. Poplack, M.D., director of Texas Children’s Cancer and Hematology Centers and Professor of Pediatric Oncology at Baylor College of Medicine. “Global HOPE will help build capacity in the region to diagnose and care for children with blood disorders and cancer, offering the potential for transformational change in survivorship for these children.”
In developing countries, including the United States, approximately 80% of Children with Cancer survive; unfortunately this figure dips markedly in developing countries including in sub-Saharan Africa.
The mortality rate is estimated to be as high as 90% across Africa, mainly due to an inadequate healthcare infrastructure, and a lack of physicians and other healthcare workers with specific training to treat children with cancer.
The most common Childhood Cancers are blood-related, including leukaemia and lymphoma.
Children with Cancer can spend weeks, months and even years undergoing chemotherapy and radiation treatments for their cancer.
Cancer is insidious and unforgiving to those children and families who have to endure it. A cancer diagnosis of any kind from leukaemia to a bone tumour, can physically, emotionally and mentally impact the entire family unit in some capacity. The financial strain of cancer treatment can also cripple a family ad place great strain on both the Child with Cancer and the rest of the Family.
For children, enduring this kind of treatment means having to deal with horrible things that children should not have to deal with; things like needle pricks, nausea, vomiting, loss of strength and hair loss. That’s why finishing chemotherapy or radiation treatment is so amazing.
A ringing bell can signify many different things, but in the life of a Cancer Warrior it means an end and a beginning – the end of all those horrific treatments and hospital stays and the beginning of life as a Survivor, a “normal” child who can once again do “normal” things.
Cancers are malignant (malicious) growths or tumours caused by abnormal and uncontrolled cell division which may spread to other parts of the body through the lymphatic system or the blood stream.
An arbitrarily adopted standard of the ages used if they are childhood cancers, are 0–14 years inclusive, that is, up to 14 years 11.9 months of age.
Paediatric oncology is the branch of medicine concerned with the diagnosis and treatment of cancer in children.
Cancer isn’t fair at any age, but perhaps no cancer is more emotionally devastating than those that occur in children. Worldwide, it is estimated that childhood cancer has an incidence of more than 250,000 per year, and a mortality rate of approximately 98,000 per year. Death from Childhood Cancer is second only to death from accidents according to the World Health Organisation (WHO).